Ambulatory blood pressure monitoring in clinical trials

Blood Pressure Monitoring

Volumn 1, Issue 3, 1996, Pages 223-225

  Staessen, Jan A ^a,b   Bieniaszewski, Leszek ^a   Celis, Hilde ^a   Thijs, Lutgarde ^a   Fagard, Robert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ambulatory monitoring; Blood pressure; Clinical trial; Hypertension

Indexed keywords

EID: 1542393880     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Armitage P, Rose GA: The variability of measurements of casual blood pressure. I. A laboratory study. Clin Sci 1966, 30:325-335.
2. Manda G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al.: Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983, ii:695-698.
3. Gould BA, Mann S, Davies AB, Altman DG, Raftery EB: Does placebo lower blood pressure? Lancet 1981, ii:1377-1381.
4. Mutti E, Trazzi S, Omboni S, Parati G, Mancia G: Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 1991, 9:361-364.
5. Staessen JA, Thijs L, Clement D, Davidson C, Fagard R, Lehtonen A, et al.: The ambulatory blood pressure decreases on long-term placebo treatment In older patients with Isolated systolic hypertension. J Hypertens 1994, 12:1035-1039.
6. Mansoor GA, White WB: Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk 1994, 1:136-142.
7. Mancia G, Di Rienzo M, Parati G: Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension 1993, 21:510-524.
8. Omboni S, Parati G, Zanchetti A, Mancia G: Calculation of the trough : peak ratio of antihypertensive treatment from ambulatory pressure: methodological aspects. J Hypertens 1995, 13:1105-1112.
9. Staessen JA, Thijs L, Bieniaszewski L, O'Brien ET, Palatini P, Davidson C, et al.: Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Hypertension 1996, 27:414-420.
10. Rose M, McMahon FG: Some problems with antihypertensive drug studies in the context of the new guidelines. Am J Hypertens 1990, 3:151-155.
11. Staessen JA, Bieniaszewski L, Buntinx F, Celis H, O'Brien ET, Van Hoof R, et al.: The trough-to-peak ratio as an instrument to evaluate antihypertensive drugs. Hypertension 1995, 26:942-949.
12. Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P: The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992, 10:385-391.
13. Conway J, Johnston J, Coats A, Somers V, Sleight P: The use of ambulatory blood pressure monitoring to Improve the accuracy and to reduce the number of subjects in clinical trials of antihypertensive agents. J Hypertens 1988, 6:111-116.
14. Staessen JA, Thijs L, Parati G, Mancia G, O'Brien ET, on behalf of the Syst-Eur Investigators: Clinical trials with ambulatory blood pressure monitoring: fewer patients needed? Lancet 1994, 344:1552-1556.